Close

Ratings by Jefferies (Akash Tewari)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/23/2024 BioMarin Pharmaceutical Inc. BMRN Maintain Buy
(N/A)
 
 
  Details
2/23/2024 Eli Lilly LLY Maintain Buy
(N/A)
 
 
  Details
2/20/2024 BioMarin Pharmaceutical Inc. BMRN Maintain Buy
(N/A)
 
 
  Details
2/13/2024 Eli Lilly LLY Maintain Buy
(N/A)
 
 
  Details
2/8/2024 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
2/6/2024 Eli Lilly LLY Maintain Buy
(Buy)
 
 
  Details
2/5/2024 Eli Lilly LLY Maintain Buy
(Buy)
 
 
  Details
2/5/2024 Apellis Pharmaceuticals APLS Upgrade Buy
(Hold)
62.13
(64.63)
4.02% Details
2/1/2024 Merck MRK Maintain Buy
(Buy)
 
 
  Details
1/26/2024 Cytokinetics CYTK Maintain Buy
(N/A)
 
 
  Details
1/18/2024 Terns Pharmaceuticals TERN Maintain Buy
(N/A)
 
 
  Details
1/18/2024 Madrigal Pharmaceuticals MDGL Maintain Buy
(N/A)
 
 
  Details
1/18/2024 Relay Therapeutics RLAY Maintain Hold
(N/A)
 
 
  Details
1/18/2024 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
1/9/2024 Merck MRK Maintain Buy
(N/A)
 
 
  Details
1/9/2024 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
12/14/2023 Pfizer PFE Maintain Buy
(N/A)
 
 
  Details
12/11/2023 Spyre SYRE New Coverage Buy
(N/A)
19.86
(34.97)
76.08% Details
12/6/2023 Arvinas Inc. ARVN Upgrade Buy
(Hold)
23.17
(46.47)
100.56% Details
11/29/2023 Merck MRK Maintain Buy
(N/A)
 
 
  Details
11/29/2023 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
11/28/2023 Acelyrin Inc SLRN Maintain Buy
(N/A)
 
 
  Details
11/28/2023 Regeneron Pharma REGN Maintain Buy
(N/A)
 
 
  Details
11/14/2023 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
11/9/2023 Eli Lilly LLY Maintain Buy
(N/A)
 
 
  Details
11/7/2023 Zentalis Pharmaceuticals ZNTL Maintain Buy
(N/A)
 
 
  Details
11/3/2023 Eli Lilly LLY Maintain Buy
(N/A)
 
 
  Details
11/2/2023 BioMarin Pharmaceutical Inc. BMRN Maintain Buy
(N/A)
 
 
  Details
10/16/2023 Pfizer PFE Upgrade Buy
(Hold)
32.92
(25.89)
-21.35% Details
10/9/2023 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
9/18/2023 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
9/12/2023 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
8/21/2023 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
8/9/2023 Eli Lilly LLY Upgrade Buy
(Hold)
454.08
(792.28)
74.48% Details
8/8/2023 Apogee Therapeutics Inc APGE New Coverage Buy
(N/A)
20.70
(41.74)
101.64% Details
8/8/2023 Enanta Pharmaceuticals ENTA Downgrade Hold
(Buy)
19.82
(15.65)
-21.04% Details
8/2/2023 Pfizer PFE Maintain Hold
(N/A)
 
 
  Details
7/21/2023 Eli Lilly LLY Maintain Hold
(N/A)
 
 
  Details
7/17/2023 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
6/28/2023 Regeneron Pharma REGN Maintain Buy
(N/A)
 
 
  Details
6/27/2023 Pfizer PFE Maintain Hold
(N/A)
 
 
  Details
6/22/2023 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
6/21/2023 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
6/7/2023 Terns Pharmaceuticals TERN New Coverage Buy
(N/A)
12.20
(7.44)
-39.02% Details
5/30/2023 Acelyrin Inc SLRN New Coverage Buy
(N/A)
19.27
(8.24)
-57.24% Details
5/19/2023 Zentalis Pharmaceuticals ZNTL Maintain Buy
(N/A)
 
 
  Details
5/4/2023 Eli Lilly LLY Maintain Hold
(N/A)
 
 
  Details
4/27/2023 BioMarin Pharmaceutical Inc. BMRN Maintain Buy
(N/A)
 
 
  Details
4/20/2023 Relay Therapeutics RLAY Upgrade Hold
(Underperform)
11.62
(10.15)
-12.65% Details
4/6/2023 Regeneron Pharma REGN Maintain Buy
(N/A)
 
 
  Details
3/24/2023 Regeneron Pharma REGN Upgrade Buy
(Hold)
751.30
(971.19)
29.27% Details
3/6/2023 Eli Lilly LLY New Coverage Hold
(N/A)
315.05
(792.28)
151.48% Details
3/6/2023 Pfizer PFE New Coverage Hold
(N/A)
40.62
(25.89)
-36.26% Details
3/6/2023 Merck MRK New Coverage Buy
(N/A)
107.01
(124.05)
15.92% Details
3/6/2023 Bristol-Myers Squibb Co. BMY New Coverage Hold
(N/A)
69.19
(50.92)
-26.41% Details
2/7/2023 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
1/17/2023 Alkermes ALKS Maintain Buy
(N/A)
 
 
  Details
12/20/2022 Madrigal Pharmaceuticals MDGL Maintain Buy
(N/A)
 
 
  Details
12/16/2022 Third Harmonic Bio THRD Downgrade Hold
(Buy)
19.80
(9.91)
-49.95% Details
12/12/2022 Acrivon Therapeutics Inc ACRV New Coverage Buy
(N/A)
12.50
(5.05)
-59.6% Details
11/29/2022 BioMarin Pharmaceutical Inc. BMRN Maintain Buy
(N/A)
 
 
  Details
10/28/2022 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
10/10/2022 Third Harmonic Bio THRD New Coverage Buy
(N/A)
20.01
(9.91)
-50.47% Details
9/9/2022 Regeneron Pharma REGN Upgrade Hold
(Underperform)
596.44
(971.19)
62.83% Details
9/7/2022 Madrigal Pharmaceuticals MDGL Maintain Buy
(N/A)
 
 
  Details
8/8/2022 Global Blood Therapeutics GBT Downgrade Hold
(Buy)
63.84
(68.49)
7.28% Details
6/21/2022 Arvinas Inc. ARVN New Coverage Hold
(N/A)
36.79
(46.47)
26.31% Details
6/6/2022 Neurocrine Bio. NBIX New Coverage Buy
(N/A)
94.42
(133.12)
40.99% Details
6/6/2022 Relay Therapeutics RLAY New Coverage
(N/A)
16.78
(10.15)
-39.51% Details
6/6/2022 Regeneron Pharma REGN New Coverage Underperform
(N/A)
630.70
(971.19)
53.99% Details
5/19/2022 Enanta Pharmaceuticals ENTA Maintain Buy
(N/A)
 
 
  Details
5/6/2022 Argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
5/3/2022 BioMarin Pharmaceutical Inc. BMRN Maintain Buy
(N/A)
 
 
  Details
4/26/2022 Cytokinetics CYTK Maintain Buy
(N/A)
 
 
  Details
4/7/2022 Enanta Pharmaceuticals ENTA Maintain Buy
(N/A)
 
 
  Details
3/29/2022 Zentalis Pharmaceuticals ZNTL Maintain Buy
(N/A)
 
 
  Details
3/4/2022 BioMarin Pharmaceutical Inc. BMRN Maintain Buy
(N/A)
 
 
  Details
2/23/2022 Alkermes ALKS Maintain Buy
(N/A)
 
 
  Details
1/10/2022 BioMarin Pharmaceutical Inc. BMRN Maintain Buy
(N/A)
 
 
  Details
11/9/2021 Alkermes ALKS Maintain Buy
(N/A)
 
 
  Details
10/7/2021 Zentalis Pharmaceuticals ZNTL New Coverage Buy
(N/A)
68.59
(14.52)
-78.83% Details
10/7/2021 argenx SE ARGX New Coverage Buy
(N/A)
294.06
(390.32)
32.73% Details
10/7/2021 Madrigal Pharmaceuticals MDGL New Coverage Buy
(N/A)
78.62
(246.56)
213.61% Details
10/7/2021 Alkermes ALKS New Coverage Hold
(N/A)
30.88
(29.92)
-3.11% Details
10/7/2021 Cytokinetics CYTK New Coverage Buy
(N/A)
36.81
(67.68)
83.86% Details
10/7/2021 Acceleron Pharma XLRN New Coverage Hold
(N/A)
177.13
(178.75)
0.91% Details
10/7/2021 BioNTech BNTX New Coverage Hold
(N/A)
250.12
(89.30)
-64.3% Details
10/7/2021 Enanta Pharmaceuticals ENTA New Coverage Buy
(N/A)
60.52
(15.65)
-74.14% Details
10/6/2021 Global Blood Therapeutics GBT New Coverage Buy
(N/A)
25.81
(68.49)
165.36% Details